Mustafa Diken speaks at Radboud UMC MMD symposium “Chemical Immunology”

Nijmegen, September 28, 2017 – The Institute for Molecular Life Sciences at Radboud University Medical Center (RIMLS) will host a mini-symposium entitled “Chemical Immunology”. The speakers will address issues and approaches in cancer therapy.

TRON’s Mustafa Diken is featured in the program and will speak about “The evolution of RNA-based vaccines against cancer.”

For more information, please see the RIMLS website.